{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T23:16:28Z","timestamp":1774566988824,"version":"3.50.1"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[1995,5,1]],"date-time":"1995-05-01T00:00:00Z","timestamp":799286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,6,28]]},"abstract":"<jats:title>SUMMARY<\/jats:title>\n               <jats:p>\u03b11-antitrypsin (\u03b11-AT) is a naturally occurring inhibitor of proteinase 3 (PR3) and elastase, two of the target antigens of anti-neutrophil cytoplasmic antibodies (ANCA). An increased incidence of \u03b11-AT phenotypes associated with dysfunctional \u03b11-AT or low serum levels has been reported in patients with anti-PR3 antibodies. We have studied the relationship between ANCA, and phenotypes and serum levels of \u03b11-AT. Phenotypes usually associated with a moderate or severe reduction in \u03b11-AT serum levels or in dysfunctional activity were found more often in individuals with anti-PR3 antibodies than in the general population: four of the 31 patients (13%) with anti-PR3 antibodies had phenotypes MZ (n= 2), S (n= 1) or Z (n= 1) (P &amp;lt; 0\u00b705). However, the corresponding \u03b11-AT serum levels were normal (n= 3) or elevated (n= 1). None of the 31 sera with anti-PR3 antibodies had low levels of \u03b11-AT. No abnormal \u03b11-AT phenotype was demonstrated in seven patients with anti-elastase antibodies, despite a low level of \u03b11-AT in one serum. Anti-myeloperoxidase antibodies are common in patients with ANCA, but no abnormal phenotype or low serum oi-AT level was demonstrated in any of 29 sera containing these antibodies. Finally anti-glomerular basement membrane (GBM) antibodies occur occasionally in patients with ANCA-associated diseases, but again none of 10 sera had an abnormal \u03b11-AT phenotype or low serum level. ANCA were not demonstrated by indirect immunofluorescence in any serum from 73 patients with abnormal \u03b11-AT phenotypes. These results confirm that patients with anti-PR3 antibodies often have \u03b11-AT phenotypes that are usually associated with low serum levels of \u03b11-AT or with dysfunctional protein. Nevertheless, the incidence of anti-PR3 antibodies in patients with abnormal \u03b11-AT phenotypes is very low. This probably reflects the rarity of Wegener's granulomatosis, the major disease associated with anti-PR3 antibodies, and the relative frequency of abnormal \u03b11-AT phenotypes. The mechanism for the development of anti-PR3 antibodies in patients with abnormal \u03b11-AT phenotypes is not clear, but may relate to the increased propensity of unbound and uninhibited PR3 to stimulate autoantibody production.<\/jats:p>","DOI":"10.1111\/j.1365-2249.1995.tb03652.x","type":"journal-article","created":{"date-parts":[[2010,7,26]],"date-time":"2010-07-26T16:42:17Z","timestamp":1280162537000},"page":"194-197","source":"Crossref","is-referenced-by-count":50,"title":["\u03b11-Antitrypsin deficiency and anti-proteinase 3 antibodies in anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis"],"prefix":"10.1093","volume":"100","author":[{"given":"J A","family":"SAVIGE","sequence":"first","affiliation":[{"name":"University Department of Medicine, Austin Hospital, Heidelberg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"CHANG","sequence":"additional","affiliation":[{"name":"University Department of Medicine, Austin Hospital, Heidelberg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"COOK","sequence":"additional","affiliation":[{"name":"Respiratory Unit, St Vincent's Hospital, Fitzroy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"BURDON","sequence":"additional","affiliation":[{"name":"Respiratory Unit, St Vincent's Hospital, Fitzroy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"DASKALAKIS","sequence":"additional","affiliation":[{"name":"Biochemistry Department, Monash Medical Centre, Clayton, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"DOERYf","sequence":"additional","affiliation":[{"name":"Biochemistry Department, Monash Medical Centre, Clayton, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"2022011517450626700_b1","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(85)91147-X","article-title":"Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis","volume":"i","author":"Van der Woude","year":"1985","journal-title":"Lancet"},{"key":"2022011517450626700_b2","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1182\/blood.V74.6.1888.1888","article-title":"Wegener's granulomatosis autoantigen is a novel neutrophil serine proteinase","volume":"74","author":"Niles","year":"1989","journal-title":"Blood"},{"key":"2022011517450626700_b3","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJM198806233182504","article-title":"Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotising and crescentic glomerulonephritis","volume":"318","author":"Falk","year":"1988","journal-title":"N Engl J Med"},{"key":"2022011517450626700_b4","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0140-6736(89)91420-7","article-title":"Circulating anti-elastase in systemic lupus erythematosus","volume":"i","author":"Nassberger","year":"1989","journal-title":"Lancet"},{"issue":"Suppl. 4","key":"2022011517450626700_b5","first-page":"F24","article-title":"Anti-neutrophil cytoplasmic antibodies and rheumatoid arthritis","volume":"8","author":"Scott","year":"1990","journal-title":"Clin Exp Rheumatol"},{"key":"2022011517450626700_b6","first-page":"A505","article-title":"Serum antineutrophil cytoplasmic autoantibodies distinguish between ulcerative colitis from Crohn's disease patients","volume":"96","author":"Targan","year":"1989","journal-title":"Gastroenterology"},{"key":"2022011517450626700_b7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.1993.tb03345.x","article-title":"ANCA and associated diseases: immunodiagnostic and pathogenetic aspects","volume":"91","author":"Gross","year":"1993","journal-title":"Clin Exp Immunol"},{"key":"2022011517450626700_b8","first-page":"206A","article-title":"Alpha 1-antitrypsin is the major inhibitor of the 29 kD cANCA antigen","volume":"XVIII","author":"Van der Wiel","year":"1991","journal-title":"Am J Kid Dis"},{"key":"2022011517450626700_b9","doi-asserted-by":"crossref","first-page":"9540","DOI":"10.1016\/S0021-9258(18)92854-1","article-title":"Characterisation of proteinase 3 (PR3), a neutrophil serine proteinase","volume":"266","author":"Rao","year":"1991","journal-title":"J Biol Chem"},{"issue":"Suppl.","key":"2022011517450626700_b10","first-page":"16A","article-title":"Anti-neutrophil cytoplasm antibodies and alpha 1-antitrypsin phenotype","volume":"93","author":"Testa","year":"1993","journal-title":"Clin Exp Immunol"},{"key":"2022011517450626700_b11","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/ki.1993.186","article-title":"Alpha 1-antitrypsin genetic polymorphism in ANCA-positive systemic vasculitis","volume":"43","author":"Esnault","year":"1993","journal-title":"Kidney Int"},{"key":"2022011517450626700_b12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0002-9343(88)80066-4","article-title":"Molecular basis of alpha 1-antitrypsin deficiency","volume":"84","author":"Brantly","year":"1988","journal-title":"Am J Med"},{"key":"2022011517450626700_b13","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1378\/chest.95.1.196","article-title":"The alpha 1-antitrypsin gene and its mutations: clinical consequences and strategies for therapy","volume":"95","author":"Crystal","year":"1989","journal-title":"Chest"},{"key":"2022011517450626700_b14","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJM197811162992003","article-title":"Alpha 1-antitrypsin deficiency (part 2)","volume":"299","author":"Morse","year":"1978","journal-title":"New Engl J Med"},{"key":"2022011517450626700_b15","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1001\/archinte.1982.00340200102021","article-title":"An overview of the pulmonary features of alpha 1-antitrypsin deficiency","volume":"142","author":"Tobin","year":"1982","journal-title":"Arch Intern Med"},{"key":"2022011517450626700_b16","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1001\/archderm.1978.01640180055013","article-title":"Alpha 1-antitrypsin deficiency associated with persistent cutaneous vasculitis","volume":"114","author":"Brandrup","year":"1978","journal-title":"Arch Dermatol"},{"key":"2022011517450626700_b17","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/0002-9343(69)90080-1","article-title":"Alpha 1-antitrypsin deficiency, emphysema, necrotising angiitis and glomerulonephritis","volume":"46","author":"Miller","year":"1969","journal-title":"Am J Med"},{"key":"2022011517450626700_b18","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/0002-9343(85)90036-1","article-title":"Severe deficiency of alpha 1-antitrypsin associated with cutaneous vasculitis, rapidly progressive glomerulonephritis, and colitis","volume":"79","author":"Lewis","year":"1985","journal-title":"Am J Med"},{"key":"2022011517450626700_b19","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1365-2249.1990.tb05433.x","article-title":"Diverse target antigens recognised by circulating antibodies in anti-neutrophil cytoplasm antibody-associated renal vasculitides","volume":"82","author":"Savige","year":"1990","journal-title":"Clin Exp Immunol"},{"key":"2022011517450626700_b20","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/clinchem\/28.1.219","article-title":"Typing of genetic variants of alpha 1-antitrypsin by electrofocusing","volume":"28","author":"Jeppsson","year":"1982","journal-title":"Clin Chem"},{"key":"2022011517450626700_b21","first-page":"12","article-title":"Delineation of a standard procedure for indirect immunofluorescence of ANCA","volume":"97","author":"Wiik","year":"1988","journal-title":"APMIS"},{"key":"2022011517450626700_b22","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4757-9182-2_54","article-title":"Alpha 1-antiproteinase and pulmonary haemorrhage in systemic vasculitis","volume-title":"ANCA-associated vasculitides: immunodiagnostic and pathogenetic value of anti-neutrophil cytoplasmic antibodies","author":"O'Donoghue","year":"1993"},{"key":"2022011517450626700_b23","first-page":"842A","article-title":"Increased mortality of PR3-ANCA-positive patients with the PiZ gene for alpha 1-antitrypsin (alpha 1-AT)","volume":"5","author":"Segelmark","year":"1994","journal-title":"JASN"},{"key":"2022011517450626700_b24","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4757-9182-2_55","article-title":"Alpha 1-antitrypsin, CRP and interleukin 6 in ANCA+ vasculitis","volume-title":"ANCA-associated vasculitides: immunodiagnostic and pathogenetic value of anti-neutrophil cytoplasmic antibodies","author":"Gronhagen-Riska","year":"1993"},{"key":"2022011517450626700_b25","article-title":"Isolation of a protein complex from purulent sputum consisting of proteinase 3 and alpha 1-antitrypsin and its use for the determination of anti-neutrophil cytoplasmic antibodies","volume-title":"ANCA-associated vasculitides: immunodiagnostic and pathogenetic value of anti-neutrophil cytoplasmic antibodies","author":"Baillieux","year":"1993"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.1995.tb03652.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/100\/2\/194\/42202532\/j.1365-2249.1995.tb03652.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/100\/2\/194\/42202532\/j.1365-2249.1995.tb03652.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,15]],"date-time":"2022-01-15T17:56:16Z","timestamp":1642269376000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/100\/2\/194\/6484243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,5]]},"references-count":25,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2008,6,28]]},"published-print":{"date-parts":[[2008,6,28]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.1995.tb03652.x","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[1995,5]]},"published":{"date-parts":[[1995,5]]}}}